Grail developed the Galleri test, a diagnostic tool designed to screen for 50 different types of cancer. This innovative test operates by analyzing a simple blood draw, aiming to provide a broad detection method for various malignancies through a non invasive approach.
However, a significant study recently concluded that the Galleri test did not demonstrate the capability to reliably detect cancers in their later stages. The research failed to provide sufficient evidence proving the test s effectiveness in identifying advanced forms of the disease.